DEF 14A: Jones Soda Co. Announces Annual Shareholder Meeting: Director Elections, Executive Pay, and Auditor Ratification on the Agenda
Proxy Statement
Jones Soda Co. will hold its annual shareholder meeting virtually on May 13, 2024, to vote on director elections, executive compensation, and the ratification of its independent auditor.
Summary
- Jones Soda Co. will hold its annual meeting of shareholders virtually on May 13, 2024, at 9:00 a.m. Seattle time.
- Shareholders of record as of March 18, 2024, are entitled to vote on the matters presented.
- The agenda includes the election of five directors for a one-year term, an advisory vote on the company's 2023 named executive officer compensation, and the ratification of Berkowitz Pollack Brant Advisors + CPAs as the company's independent registered public accounting firm for the fiscal year ending December 31, 2024.
- The Board of Directors recommends voting for the company's nominated directors, the approval of executive compensation, and the ratification of the auditor appointment.
- Shareholders can attend the virtual meeting, vote electronically, and submit questions online.
- The company is providing proxy materials online to reduce costs and environmental impact.
- Shareholders can vote by internet, phone, or mail.
- The Board knows of no other matters that will be presented for consideration at the Annual Meeting.
Sentiment
Score: 7
Explanation: The document is primarily factual and procedural, outlining the agenda and processes for the annual shareholder meeting. While there are some minor negative aspects, such as late filings, the overall tone is neutral and focused on compliance and governance.
Positives
- The company is embracing a virtual format for the annual meeting, which provides a consistent experience for all shareholders regardless of location.
- The company is making proxy materials available online, which lowers costs and reduces environmental impact.
- The Board of Directors is actively engaged in risk oversight and corporate governance.
- The company has a Code of Ethics and a Code of Conduct in place.
- The company prohibits hedging and pledging of its securities by officers, directors, and employees.
Negatives
- David Knight filed a late Form 3 on July 10, 2023.
- Gregg Reichman filed a late Form 4 on May 17, 2023 and December 20, 2023.
- Paul Norman filed a late Form 4 on September 22, 2023.
- Ronald Dissinger filed a late Form 3 on June 9, 2023 and a late Form 4 on June 9, 2023.
- Eric Chastain resigned from the Company effective March 12, 2024.
Risks
- Failure to achieve a quorum at the Annual Meeting could necessitate adjournment.
- Advisory vote on executive compensation may not align with shareholder sentiment.
- Potential for other matters to be properly brought before the Annual Meeting, requiring the proxy holders to vote at their discretion.
- The company dismissed Armanino LLP as its independent registered public accounting firm on July 18, 2023.
- The company restated its consolidated financial statements as of and for the year ended December 31, 2021, and corrected the unaudited quarterly financial information for period endings March 31, 2022 and June 30, 2022.
Future Outlook
The company intends to hold the 2025 annual meeting of shareholders in May 2025.
Industry Context
The document reflects standard corporate governance practices for publicly traded companies, including the solicitation of proxies, disclosure of executive compensation, and the role of the board of directors in overseeing risk management and financial reporting. The virtual meeting format aligns with a growing trend in corporate governance to enhance accessibility and reduce costs.
Comparison to Industry Standards
- The proxy statement adheres to SEC regulations, similar to those of comparable publicly traded companies.
- The structure of the board and its committees (Audit, Compensation and Governance, Mergers and Acquisitions and Investments) is typical of companies listed on the Nasdaq Stock Market.
- Executive compensation disclosures follow SEC guidelines, providing transparency to shareholders.
- The process for director nominations and evaluations aligns with best practices in corporate governance.
- The company's Code of Ethics and Code of Conduct are standard for maintaining ethical business practices.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| President and Chief Executive Officer | Mark Murray | David Knight | June 23, 2023 | Mark Murray retired from the Company |
| Chief Operating Officer | Eric Chastain | Eric Bittner | March 12, 2024 | Eric Chastain resigned from the Company |
| Chief Growth Officer | NA | Jerry Goldner | October 23, 2023 | NA |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Compensation Policy | The Board decided to amend its policy concerning non-employee director compensation to remove the cash compensation portion and only issue stock options. | May 25, 2023 | This change may impact the attractiveness of serving on the board for some individuals. |
Stakeholder Impact
- Shareholders have the opportunity to vote on key decisions affecting the company's direction and governance.
- Executive officers' compensation is subject to shareholder advisory vote, influencing future compensation decisions.
- Employees are subject to the company's Code of Conduct and Ethics, promoting ethical behavior.
- The selection of an independent auditor ensures the integrity of financial reporting, impacting investor confidence.
Next Steps
- Shareholders are encouraged to vote on the proposals outlined in the proxy statement.
- The company will hold the annual meeting on May 13, 2024.
- The company will file a Form 8-K with the SEC to disclose the final voting results within four business days after the Annual Meeting.
Key Dates
| Date | Description |
|---|---|
| July 11, 2019 | Date of Investor Rights Agreement (IRA) with Heavenly Rx Ltd. |
| November 3, 2020 | Date of stock option grants to Mark Murray. |
| March 8, 2021 | Joe Culp appointed Principal Accounting Officer. |
| March 23, 2021 | Date of stock option grants to Eric Chastain and Joe Culp. |
| May 19, 2021 | Mark Murray appointed as a director of Jones Soda. |
| May 18, 2021 | Date of stock option grant to Mark Murray. |
| September 30, 2021 | Board of Directors approved an amendment to the 2011 Plan. |
| November 8, 2021 | Eric Chastain appointed as the President of the Jones Beverage Division. |
| November 23, 2021 | Joe Culp ceased being Principal Financial Officer. |
| March 15, 2022 | Board of Directors adopted the 2022 Plan; Paul Norman became Chairman of the Board. |
| March 15, 2022 | Joe Culp appointed Interim Chief Financial Officer and Principal Accounting Officer. |
| May 16, 2022 | 2022 Plan became effective upon approval by shareholders. |
| May 27, 2022 | Company entered into an employment agreement with Mark Murray. |
| August 15, 2022 | 600,000 RSUs vested for Mark Murray. |
| December 30, 2022 | Company entered into a rescission agreement with Mark Murray. |
| February 15, 2023 | Board granted 1,800,000 RSUs to Mark Murray; Board granted stock options to non-employee directors. |
| February 16, 2023 | Eric Chastain's annual base salary was increased. |
| February 27, 2023 | Gregg Reichman appointed as a director of Jones Soda. |
| February 28, 2023 | Board of Directors approved cash bonuses for Mark Murray and Eric Chastain. |
| April 1, 2023 | Jamie Colbourne resigned from the Board. |
| April 3, 2023 | Board granted stock options to Gregg Reichman; Notice of Internet Availability of Proxy Materials mailed. |
| May 15, 2023 | 600,000 RSUs were to vest for Mark Murray. |
| May 25, 2023 | Ronald Dissinger appointed as a director of Jones Soda; Board decided to amend its policy concerning non-employee director compensation. |
| June 8, 2023 | Company and Mark Murray entered into a Release of Claims Agreement. |
| June 9, 2023 | Ronald Dissinger filed a late Form 3 and a late Form 4. |
| June 23, 2023 | David Knight appointed as President and Chief Executive Officer; Mark Murray retired from the Company. |
| July 10, 2023 | David Knight filed a late Form 3. |
| July 14, 2023 | Berkowitz Pollack Brant engaged as independent registered public accounting firm. |
| July 18, 2023 | Jones Soda Co. dismissed Armanino LLP as its independent registered public accounting firm. |
| August 15, 2023 | 600,000 RSUs were to vest for Mark Murray. |
| September 15, 2023 | Paul Norman acquired shares of the Company's common stock upon the exercise of a stock purchase warrant. |
| September 22, 2023 | Paul Norman filed a late Form 4. |
| October 23, 2023 | Jerry Goldner appointed as the Company's Chief Growth Officer. |
| December 5-8, 2023 | Gregg Reichman purchased an aggregate of 150,000 shares of the Company's common stock on the open market. |
| December 6, 2024 | Deadline for shareholder proposals for the 2025 annual meeting to be included in the Proxy Statement. |
| January 13, 2025 | Earliest date for shareholder notice of proposals (other than director nominations) for the 2025 annual meeting. |
| February 12, 2025 | Latest date for shareholder notice of proposals (other than director nominations) for the 2025 annual meeting. |
| March 12, 2024 | Eric Bittner appointed as the Company's Chief Operating Officer; Eric Chastain resigned from the Company. |
| March 18, 2024 | Record date for the 2024 Annual Meeting. |
| April 3, 2024 | Date of Proxy Statement. |
| May 13, 2024 | Date of the 2024 Annual Meeting. |
| May 25, 2024 | First vesting date for Ronald Dissinger's stock options. |
| June 19, 2024 | First vesting date for David Knight's stock options. |
| August 15, 2024 | Final vesting date for Mark Murray's RSUs. |
| December 31, 2024 | Fiscal year end for which Berkowitz Pollack Brant is proposed as the independent auditor. |
| May 2025 | Intended date for the 2025 annual meeting of shareholders. |
Keywords
annual meeting, proxy statement, directors, executive compensation, Berkowitz Pollack Brant, shareholders, voting, governance, Jones Soda Co.
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.